Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOMELOTINIB vs MOMETASONE FUROATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOMELOTINIB vs MOMETASONE FUROATE: Safety Overview

Metric MOMELOTINIB MOMETASONE FUROATE
Total FAERS Reports 909 11,619
Deaths Reported 143 138
Death Rate 15.7% 1.2%
Hospitalizations 213 1,865
Average Patient Age 73.2 yrs 56.1 yrs
% Female Patients 49.4% 65.1%
FDA Approval Date Sep 15, 2023 Apr 18, 2007
Manufacturer GlaxoSmithKline LLC Bryant Ranch Prepack
Route ORAL TOPICAL
Marketing Status Prescription Discontinued